{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T08:10:36Z","timestamp":1689322236882},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bone Marrow Cancer Research Trust"},{"name":"Ruth Spearing Cancer Research Trust"},{"DOI":"10.13039\/501100001530","name":"Canterbury Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.leukres.2014.06.004","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T15:16:38Z","timestamp":1402672598000},"page":"1217-1223","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC"],"prefix":"10.1016","volume":"38","author":[{"given":"B.D.","family":"Hock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Macpherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J.","family":"Fernyhough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2014.06.004_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11899-011-0106-x","article-title":"Immune reconstitution in chronic lymphocytic leukemia","volume":"7","author":"Riches","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.leukres.2014.06.004_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/bmb\/ldn034","article-title":"The immunodeficiency of chronic lymphocytic leukaemia","volume":"87","author":"Hamblin","year":"2008","journal-title":"Br Med Bull"},{"key":"10.1016\/j.leukres.2014.06.004_bib0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T cell immunological synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0025","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2014.06.004_bib0030","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2012-08-448332","article-title":"Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide","volume":"121","author":"Ramsay","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0035","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells","volume":"115","author":"Gorgun","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2014.06.004_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2011.04466.x","article-title":"Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells","volume":"166","author":"Piper","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Burger","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/10428194.2011.610014","article-title":"Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches","volume":"53","author":"Hayden","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2014.06.004_bib0055","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","article-title":"A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease","volume":"117","author":"Bagnara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00262-012-1320-7","article-title":"CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients","volume":"62","author":"Borge","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2014.06.004_bib0065","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","article-title":"CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment","volume":"111","author":"Patten","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/cimm.1998.1360","article-title":"Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro","volume":"189","author":"Tretter","year":"1998","journal-title":"Cell Immunol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0075","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1182\/blood-2012-11-467670","article-title":"IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells","volume":"122","author":"Pascutti","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.celrep.2013.07.011","article-title":"Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells","volume":"4","author":"Os","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.leukres.2014.06.004_bib0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2141.2004.05240.x","article-title":"Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy","volume":"127","author":"Spaner","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4049\/jimmunol.153.2.666","article-title":"T lymphocyte T cell-B cell-activating molecule\/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7\/BB-1) and enhance their costimulatory activity","volume":"153","author":"Yellin","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.177.4.925","article-title":"Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal","volume":"177","author":"Ranheim","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2014.06.004_bib0100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaut.2011.01.005","article-title":"Human T cells induce their own regulation through activation of B cells","volume":"36","author":"Lemoine","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.leukres.2014.06.004_bib0105","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1182\/blood-2008-02-140087","article-title":"Induction of CD4+ T-cell anergy and apoptosis by activated human B cells","volume":"112","author":"Tretter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0110","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/eji.201040673","article-title":"IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro","volume":"40","author":"Bouaziz","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2013-02-482406","article-title":"Adenosine production by human B cells and B cell-mediated suppression of activated T cells","volume":"122","author":"Saze","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0120","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cncr.21816","article-title":"Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies","volume":"106","author":"Hock","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2014.06.004_bib0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imm.12004","article-title":"Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability","volume":"137","author":"Hock","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2014.06.004_bib0130","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1182\/blood-2011-06-275610","article-title":"CD38 and chronic lymphocytic leukemia: a decade later","volume":"118","author":"Malavasi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0135","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1172\/JCI70013","article-title":"Allogeneic T cell responses are regulated by a specific miRNA-mRNA network","volume":"123","author":"Sun","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2014.06.004_bib0140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2013-08-518183","article-title":"CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia","volume":"123","author":"Te Raa","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0145","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood-2013-12-540922","article-title":"Hanging tough: CMV-specific CD8+ T cells in CLL","volume":"123","author":"Riches","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0150","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood-2010-05-284505","article-title":"Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo","volume":"116","author":"Seiffert","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/leu.2011.179","article-title":"Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling","volume":"26","author":"Epron","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.06.004_bib0160","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.0212064","article-title":"IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells","volume":"92","author":"Sinha","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0170","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/eji.201242594","article-title":"New helping friends for B cells","volume":"42","author":"Cerutti","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2014.06.004_bib0175","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V100.5.1795.h81702001795_1795_1801","article-title":"Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1","volume":"100","author":"Pedersen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.06.004_bib0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1445-5994.2009.02135.x","article-title":"CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data","volume":"40","author":"Hock","year":"2010","journal-title":"Intern Med J"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T07:50:43Z","timestamp":1689321043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212614001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0145212614001830"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.06.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}